Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PERCIVIA, a developer of recombinant therapeutic proteins using the PER.C6 human cell line with a focus on bio-better and bio-similar projects, has appointed Amit Munshi as the new president and CEO.
Subscribe to our email newsletter
Munshi is a co-founder and the former chief business officer of KYTHERA Biopharmaceuticals.
Before KYTHERA, Munshi was the general manager of Amgen’s European Nephrology Business, with responsibility for Amgen lead product for anemia management.
PERCIVIA board of directors member Stephan Tanda said Amit brings with him 20 years of experience building successful global businesses.
"He has demonstrated an entrepreneurial vision both in start-up environments and within larger corporate enterprises – making him uniquely suited to lead PERCIVIA," Tanda said.